AVEO Oncology (NASDAQ: AVEO) reported Q3 EPS of $0.10, versus ($0.18) reported last year. Revenue for the quarter came in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE